New genetic variants of influenza A(H1N1)pdm09 detected in Cuba during 2011-2013.

Influenza A(H1N1)pdm09 virus has evolved continually since its emergence in 2009. For influenza virus strains, genetic changes occurring in HA1 domain of the hemagglutinin cause the emergence of new variants. The aim of our study is to establish genetic associations between 35 A(H1N1)pdm09 viruses circulating in Cuba in 2011-2012 and 2012-2013 seasons, and A/California/07/2009 strain recommended by WHO as the H1N1 component of the influenza vaccine. The phylogenetic analysis revealed the circulation of clades 3, 6A, 6B, 6C and 7. Mutations were detected in the antigenic site or in the receptor-binding domains of HA1 segment, including S174P, S179N, K180Q, S202T, S220T and R222K. Substitutions S174P, S179N, K180Q and R222K were detected in Cuban strains for the first time.

Casos de poliomielitis paralítica asociada a la vacuna oral antipoliomielítica en Cuba (1963-2006) / Cases of paralytic poliomyelitis associated with oral antipoliomielytis vaccine in Cuba (1963-2006)

Objetivo: divulgar los indicadores de poliomielitis paralítica asociada encontrados en 44 años en niños vacunados con oral antipoliomielítica, suministrada exclusivamente en campañas masivas de vacunación durante el período de 1963 a 2006 y reportar el riesgo de poliomielitis paralítica asociada a la vacuna con relación a diferentes aspectos epidemiológicos. Métodos: se realizó un estudio retrospectivo en 596 casos de parálisis fláccida aguda en niños ingresados en hospitales pediátricos, basado en investigaciones virológicas y detección de diferentes variables epidemiológicas. Resultados: de 113 pacientes estudiados se aislaron 120 agentes virales y 30 fueron identificados como poliovirus. Los datos clínicos y epidemiológicos en 596 casos de parálisis fláccida aguda permitieron categorizar a 20 niños afectados con poliomielitis paralítica asociada a la vacuna. Todos los casos se presentaron en niños menores de un año, vacunados con oral antipoliomielítica con estrategias de campañas masivas de vacunación exclusivamente y 19 fueron producidos por la primera dosis. El riesgo global en los niños vacunados con primera dosis de 1963 a 2006 fue 1 en 379 888 (7 217 866 dosis administradas/19 casos con poliomielitis paralítica asociada a la vacuna). Los casos de poliomielitis paralítica asociada a la vacuna se han presentado esporádicos o en un grupo de 8 casos en el período 1989-1992. El riesgo de primera dosis en casos esporádicos fue 1 en 612 864 y en el grupo de 1 en 84 670. El riesgo en casos agrupados es 7,2 veces mayor que los ocurridos en casos aislados. Particularmente en el año 1992, que coincidió con una epidemia de neuropatía epidémica, el riesgo fue de 1 en 52 140, lo que representó un incremento de 11,8 veces a lo ocurrido en casos esporádicos. Los niños de 4-7 meses de edad también tuvieron un riesgo mayor que fue 1 en 132 812....(AU)

Aim: to disseminate the indicators of associated paralytic poliomyelitis found during 44 years in children that received the oral antipoliomyelitis vaccine, which was only administered in massive vaccination campaigns from 1963 to 2006, and to report the risk of vaccine-associated paralytic poliomyelitis as regards different epidemiological aspects. Methods: a retrospective study was undertaken in 596 cases of acute flaccid paralysis in children admitted in pediatric hospitals, based on virology researches, and on the detection of different epidemiological variables. Results: 120 viral agents were isolated from 113 studied patients. 30 were identified as poliovirus. The clinical and epidemiological data from 596 cases of acute flaccid paralysis allowed to categorize 20 children affected with vaccine-associated paralytic poliomyelitis. All the cases were children under one that were exclusively administered the oral antipoliomyelitis vaccine through the strategy of the massive vaccination campaigns. 19 of them were caused by the first dose. Global risk in children vaccinated with the first dose from 1963-2006 was of one in 379 888 (7 217 866 doses administered/19 cases with vaccine-associated paralytic poliomyelitis). Cases of vaccine-associated paralytic poliomyelitis have been sporadic or in a group of 8 cases during 1989-1992. The risk of first dose in sporadic cases was of one in 612 864, and in the group of 1 in 84 670. The risk of grouped cases is 7.2 times higher than those occurred in isolated cases. Particularly, in 1992, coinciding with an outbreak of epidemic neuropathy, the risk was of one in 52 140, which represented an increase of 11.8 times compared with sporadic cases. Children aged 4-7 months old also had a higher risk of 1 in 132 812. Conclusions: there were identified epidemiological aspects that augmented the risk of vaccine-associated paralytic poliomyelitis, in which the aspects of nutritional deficiencies coincided(AU)

Casos de poliomielitis paralítica asociada a la vacuna oral antipoliomielítica en Cuba (1963-2006) / Cases of paralytic poliomyelitis associated with oral antipoliomielytis vaccine in Cuba (1963-2006)

Objetivo: divulgar los indicadores de poliomielitis paralítica asociada encontrados en 44 años en niños vacunados con oral antipoliomielítica, suministrada exclusivamente en campañas masivas de vacunación durante el período de 1963 a 2006 y reportar el riesgo de poliomielitis paralítica asociada a la vacuna con relación a diferentes aspectos epidemiológicos. Métodos: se realizó un estudio retrospectivo en 596 casos de parálisis fláccida aguda en niños ingresados en hospitales pediátricos, basado en investigaciones virológicas y detección de diferentes variables epidemiológicas. Resultados: de 113 pacientes estudiados se aislaron 120 agentes virales y 30 fueron identificados como poliovirus. Los datos clínicos y epidemiológicos en 596 casos de parálisis fláccida aguda permitieron categorizar a 20 niños afectados con poliomielitis paralítica asociada a la vacuna. Todos los casos se presentaron en niños menores de un año, vacunados con oral antipoliomielítica con estrategias de campañas masivas de vacunación exclusivamente y 19 fueron producidos por la primera dosis. El riesgo global en los niños vacunados con primera dosis de 1963 a 2006 fue 1 en 379 888 (7 217 866 dosis administradas/19 casos con poliomielitis paralítica asociada a la vacuna). Los casos de poliomielitis paralítica asociada a la vacuna se han presentado esporádicos o en un grupo de 8 casos en el período 1989-1992. El riesgo de primera dosis en casos esporádicos fue 1 en 612 864 y en el grupo de 1 en 84 670. El riesgo en casos agrupados es 7,2 veces mayor que los ocurridos en casos aislados. Particularmente en el año 1992, que coincidió con una epidemia de neuropatía epidémica, el riesgo fue de 1 en 52 140, lo que representó un incremento de 11,8 veces a lo ocurrido en casos esporádicos. Los niños de 4-7 meses de edad también tuvieron un riesgo mayor que fue 1 en 132 812. Conclusiones: se identificaron aspectos epidemiológicos que incrementaron el riesgo de poliomielitis paralítica asociada a la vacuna, en los cuales coinciden aspectos de deficiencias nutricionales.

Aim: to disseminate the indicators of associated paralytic poliomyelitis found during 44 years in children that received the oral antipoliomyelitis vaccine, which was only administered in massive vaccination campaigns from 1963 to 2006, and to report the risk of vaccine-associated paralytic poliomyelitis as regards different epidemiological aspects. Methods: a retrospective study was undertaken in 596 cases of acute flaccid paralysis in children admitted in pediatric hospitals, based on virology researches, and on the detection of different epidemiological variables. Results: 120 viral agents were isolated from 113 studied patients. 30 were identified as poliovirus. The clinical and epidemiological data from 596 cases of acute flaccid paralysis allowed to categorize 20 children affected with vaccine-associated paralytic poliomyelitis. All the cases were children under one that were exclusively administered the oral antipoliomyelitis vaccine through the strategy of the massive vaccination campaigns. 19 of them were caused by the first dose. Global risk in children vaccinated with the first dose from 1963-2006 was of one in 379 888 (7 217 866 doses administered/19 cases with vaccine-associated paralytic poliomyelitis). Cases of vaccine-associated paralytic poliomyelitis have been sporadic or in a group of 8 cases during 1989-1992. The risk of first dose in sporadic cases was of one in 612 864, and in the group of 1 in 84 670. The risk of grouped cases is 7.2 times higher than those occurred in isolated cases. Particularly, in 1992, coinciding with an outbreak of epidemic neuropathy, the risk was of one in 52 140, which represented an increase of 11.8 times compared with sporadic cases. Children aged 4-7 months old also had a higher risk of 1 in 132 812. Conclusions: there were identified epidemiological aspects that augmented the risk of vaccine-associated paralytic poliomyelitis, in which the aspects of nutritional deficiencies coincided.

First report on fatal myocarditis associated with adenovirus infection in Cuba.

Myocarditis is caused frequently by viral infections of the myocardium. In the past, enteroviruses (EV) were considered the most common cause of myocarditis in all age groups. Other viruses that cause myocarditis are adenovirus and influenza viruses. Parvovirus B19 infection is associated sometimes with myocarditis. Members of the Herpesviridae family, cytomegalovirus (CMV), and human herpesvirus 6 (HHV-6) have been associated occasionally with myocarditis. During an atypical outbreak of acute febrile syndrome, eight children, with ages from 5 months to 15 years, died in cardiogenic shock due to myocarditis in July-August 2005, in the city of Havana, Cuba. Nested polymerase chain reaction (nPCR) and nested reverse transcription-PCR (nRT-PCR) were carried out on fresh heart muscle and lung tissue to analyze the genomic sequences of adenovirus, CMV, HHV-6, herpes simplex virus, Epstein-Barr virus (EBV), varizella zoster virus, influenza virus A, B, C, respiratory syncytial virus (RSV) A and B, parainfluenza viruses, rhinoviruses, coronavirus, flaviruses and enteroviruses. Evidence was for the presence of the adenovirus genome in 6 (75%) of the children. Phylogenetic analyses of a conserved hexon gene fragment in four cases showed serotype 5 as the causal agent. No others viruses were detected. Histological examination was undertaken to detect myocardial inflammation. After exclusion of other possible causes of death, the results indicated that viral myocarditis was the cause of death in patients with adenovirus infection.

A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005.

BACKGROUND: Among multiple causes of acute myocarditis, viral infection, especially that due to enteroviruses and adenoviruses, is the leading cause. In the summer 2005 an outbreak of a febrile syndrome accompanied by acute cardiac decompensation occurred in infants and young children in Havana City. Eleven patients had a rapid evolution of disease and there were 8 fatalities from cardiac failure secondary to myocarditis. OBJECTIVE: The aim of the present study was to determine the etiological agent responsible for this outbreak. STUDY DESIGN: Children admitted to the pediatric hospitals of Havana City from July 3 to August 2 with this clinical presentation were studied. Forty samples of necropsy tissue, cerebrospinal fluid, stools and serum were tested by molecular methods for 14 respiratory viruses, 6 herpesviruses and generic enteroviruses and flavirus and alfaviruses. Viral isolation was performed in A-549 cells. Isolated viruses were typed by sequence analysis. RESULTS: Adenovirus genome was detected in 6 of the 8 fatal cases-the lungs in 5 (63%) and the myocardium in 3 (37%). In two fatal cases, viral genome was detected in both lung and myocardium. Adenovirus was isolated in five fatal cases. In all three non-fatal cases, adenovirus genome was detected and adenovirus was isolated into two. Sequence analysis showed that adenovirus type 5 was the only isolate from fatal cases and adenovirus 1 the only isolate in non-fatal cases. No other viruses were found by PCR or isolation techniques. CONCLUSION: Adenovirus was the etiologic agent implicated in this myocarditis outbreak and adenovirus type 5 was associated with fatal outcome.

Producción de un antisuero específico contra la cepa A/Johannesburg/33/94 (H3N2), y su utilidad en la caracterización de aislamientos de virus de influenza en ratas Wistar / Production of a specific antiserum against strain A/Johannesburg/33/94 (H3N2), and its usefulness in

Se obtuvo un antisuero policlonal con alto título, alta especificidad y sensibilidad, contra la hemaglutinina de la cepa de influenza A/Johannesburg/33/94 que pertenece al subtipo A (H3N2). Se describe el proceso de obtención del antígeno o inmunógeno, el esquema de inmunización y su aplicación a las ratas Wistar como modelo animal; y se validó mediante la técnica de inhibición de la hemaglutinación (IH). El antisuero obtenido fue tratado con enzima destructora de receptores de producción nacional (EDR/IPK) para la eliminación de inhibidores inespecíficos de la IH. La validación se realizó frente a un panel que incluyó 9 cepas de referencia de influenza de los subtipos A(H3N2), A(H1N1) y el tipo B. No se detectaron reacciones inespecíficas frente a cepas A(H1N1) y del tipo B. Se determinó el tipo y subtipo de aislamientos autóctonos con resultados satisfactorios(AU)

Respiratory syncytial virus group A and B genotypes and disease severity among Cuban children.

BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of serious lower tract infections in infants. Comorbid conditions such as chronic diseases and prematurity have been associated with greater severity illness, but virus genotypes and disease severity is still unknown. METHODS: Forty selected strains of RSV group A and B from Cuban infants with acute respiratory disease (ARD) over five seasons were studied. Viral RNA was extracted and polymerase chain reaction (PCR) was carried out using direct primers directed to parts of the nucleoprotein (N) and fusion (F) genes, respectively. Amplicons were digested using restriction fragment length polymorphism (RFLP) to define the association between virus and disease severity. Disease severity was assessed as very mild, mild, moderate, and severe. RESULTS: Three of six known N genotypes were detected. NP4 and NP3 were found more frequently; moreover, it was difficult to establish a relationship between N genotypes and disease severity. Five genotypes in F gene were found: F1, F2, F5, F9 and F11; F9 and F11 were associated with very mild disease, but F1 genotype appears to be associated with moderate to severe disease. CONCLUSIONS: At least five combinations of N and F genotypes circulated in the studied infants in Cuba. Patients with F1NP4 genotype showed moderate to severe disease. Relationship between genotypes and disease severity was established.

Circulación silenciosa de poliovirus demostrada por interferencia a los enterovirus no polio / Silent circulation of poliovirus demonstrated by interference against non-polio enterovirus

Se obtuvieron muestras de heces semanalmente, en niños menores de 3 años para aislar los poliovirus y enterovirus no polio, con el objetivo de incrementar el conocimiento de las circulaciones de los derivados de la vacuna durante las campañas masivas. Los esquemas de vacunación continua permiten la circulación de esos virus durante grandes períodos de tiempo. En los niños se demostró una interferencia de los enterovirus no polio por los poliovirus vacunales. Sin embargo, mientras los bajos porcentajes de enterovirus no polio no mostraron diferencias significativas, sí se encontró en los altos porcentajes de poliovirus vacunales aislados en niños menores de 1 año en relación con los de 1 y 2 años. Basados en esa contradicción, se estimó la circulación silenciosa de los poliovirus por cálculos matemáticos. Con los poliovirus estimados se permitió obtener las curvas simuladas. Posteriormente, en otra investigación se confirmaron los resultados por métodos inmunológicos

Circulación silenciosa de poliovirus demostrada por interferencia a los enterovirus no polio / Silent circulation of poliovirus demonstrated by interference against non-polio enterovirus

Se obtuvieron muestras de heces semanalmente, en niños menores de 3 años para aislar los poliovirus y enterovirus no polio, con el objetivo de incrementar el conocimiento de las circulaciones de los derivados de la vacuna durante las campañas masivas. Los esquemas de vacunación continua permiten la circulación de esos virus durante grandes períodos de tiempo. En los niños se demostró una interferencia de los enterovirus no polio por los poliovirus vacunales. Sin embargo, mientras los bajos porcentajes de enterovirus no polio no mostraron diferencias significativas, sí se encontró en los altos porcentajes de poliovirus vacunales aislados en niños menores de 1 año en relación con los de 1 y 2 años. Basados en esa contradicción, se estimó la circulación silenciosa de los poliovirus por cálculos matemáticos. Con los poliovirus estimados se permitió obtener las curvas simuladas. Posteriormente, en otra investigación se confirmaron los resultados por métodos inmunológicos(AU)

[Silent circulation of poliovirus demonstrated by interference against non-polio enterovirus]. / Circulación silenciosa de poliovirus demostrada por interferencia a los enterovirus no polio.

Fecal samples were weekly obtained from children under 3 years of age to isolate non-polio poliovirus and enterovirus and to expand the knowledge on circulation of vaccine-derived viruses during mass campaigns. The steady vaccination schedules allow the circulation of these viruses for long periods of time. The interference of non-polio enterovirus by vaccine poliovirus was demonstrated in children. However, the low percentages of non-polio enterovirus did not show significant differences whereas these differences were significant in high percentages of vaccine poliovirus isolated in children under one year-old in comparison with those of 1 and 2 years of age. Based on this contradiction, mathematical calculations estimated the silent circulation of poliovirus that in turn made it possible to draw simulated curves. The results were later confirmed in another research work by using immunological methods.

[Different circulation patterns of subgroups A and B of human respiratory syncytial virus in some provinces of Cuba]. / Diferentes patrones de circulación dentro de los subgrupos A y B del virus sincitial respiratorio humano en algunas provincias de Cuba.

The nucleotide sequencing of the protein G C-terminal region of 37 samples taken from nasopharyngeal washings of under one-year old children from some Cuban provinces was made for 5 epidemic periods (1995-2000) to find out the circulation patterns of strains of human respiratory syncytial virus that is classified in two antigenic subgroups known as A and B; each of them contains multiple variants. Subgroup A has circulated during all these years but subgroup B was detected only in the year 2000. The presence of strains with two different sizes of protein G (297 aa and 298 aa) was observed whereas subgroup B showed only one size (295 aa). Phylogenetic analysis allowed identifying 5 and 2 genotypes within subgroups A and B respectively. Viruses present in Cuba were phylogenetically related to the strains of other parts of the world. Subgroup A comprised two strains very similar to Long prototype strain. Almost all the strains of both subgroups in the year 2000 phylogenetically related with strains that circulated in South Africa during the same period.

Isolation and identification of Adenovirus in hospitalized children, under five years, with acute respiratory disease, in Havana, Cuba

Nine Adenovirus (Ad) strains isolated in Cuba, from 128 nasopharingeal swab specimens of children below five years old, with acute respiratory diseases, during 1996 and 1997, were studied by restriction enzyme analysis of genomic DNA with two endonucleases BamH I and Sma I. All different fragment patterns were compared with the respective prototypes. The identified adenoviruses were Ad 1 (n=4), Ad 2 (n=1) and Ad 6 (n=4). Males were more frequently infected than females. The analysis of the occurrence of these Adenovirus strains of subgenus C revealed that Ad 1 and Ad 6 were the predominant serotypes in 1996 and in 1997, respectively

Neumonía hemorrágica por Influenza virus: diagnóstico virológico / Hemorrhagic pneumonia caused by influenza virus: virological diagnosis

The paper presents the case of a female patient who was admitted to "Calixto GarcÝa" General Hospital with respiratory distress and hypovolemic or septic shock. She was diagnosed with viral hemorrhagic pneumonia. From the endotracheal secretion taken as a sample, the influenza virus was isolated as etiological agent, which, through the hemaglutination inhibition technique, was characterized as a strain belonging to H3N2 subtype, very similar to strain A/Johannesburg/33/94 from the antigenic viewpoint. The patient recovered satisfactorily after being treated with rivabirin.

Neumonía hemorrágica por Influenza virus: diagnóstico virológico / Pneumonia hemorrágica for Influenza virus: diagnosis virológico

Se presentó el caso de una paciente que ingresó en el Hospital General Calixto García por tener síntomas respiratorios y estado de choque hipovolémico o séptico. Se diagnosticó neumonía hemorrágica viral. A partir de la secreción endotraqueal tomada como muestra se aisló el virus de influenza como agente etiológico, y se caracterizó como una cepa perteneciente al subtipo H3N2, parecida antigénicamente a la cepa A/Johannesburg/33/94, mediante la técnica de inhibición de la hemaglutinación. La paciente evolucionó hacia la curación luego de recibir tratamiento con rivabirín(AU)

Antigenic and Genetic Characterization of Twenty-six Strains of Human Respiratory Syncytial Virus (Subgroup A) Isolated During Three Consecutive Outbreaks in Havana City, Cuba

Twenty-six human respiratory syncytial virus strains (subgroup A) isolated from three outbreaks in Havana City during the period 1994/95, 1995/96 and 1996/97 were analyzed to determine their antigenic and genetic relationships. Analyses were performed by monoclonal antibodies and restriction mapping (N gene) following amplification of the select region of the virus genome by polymerase chain reaction. All isolated strains were classified as subgroup A by monoclonal antibodies and they showed a restriction pattern NP4 that belonged to subgroup A. Thus the results obtained in this work, showed a close relation (100 percent) between antigenic and genetic characterization of the isolated strains in our laboratory. These methods permit the examination of large numbers of isolates by molecular techniques, simplifying the researchs into the molecular epidemiology of the virus

Variabilidad antigénica de cepas de virus sincitial respiratorio aisladas en ciudad de la Habana mediante ELISA utilizando anticuerpos monoclonales / Antigenic variance of strains of the espiratory sincitial virus isolated in Habana city by eans of ELISA using antibodies

Se realizó el estudio de caracterización y análisis de la variabilidad antigénica con un panel de 10 anticuerpos monoclonales que reconocen a epítopes lineales de la protéina G, a 15 cepas de Virus Sincitial Respiratorio aisladas en dos brotes ocurridos en Ciudad Habana entre los meses de octubre a enero (1994-1995) y octubre (1996), respectivamente. Para ello se utilizaron dos cepas de referencia: la Cepa Long y la Cepa A/Mon/3/88. El ELISA fue el método empleado para los ensayos. Los resultados mostraron la variabilidad de la proteína G entre los aislamientos y su relación antigénica con la cepa prototipo Long, además de confirmar que todas las cepas que habían circulado en estos períodos correspondían antigénicamente al Subgrupo A